TY  - GEN
AU  - First,M R
AU  - Weiskittel,P
AU  - Burton,M L
AU  - Shah,M B
AU  - Dreyer,D
AU  - Fleck,P
AU  - Bey,C
AU  - Peddi,V R
AU  - Canafax,D M
AU  - Schroeder,T J
TI  - Nine-month follow-up of SangCya (Sang-35) in kidney transplant patients after conversion from Sandimmune
SN  - 0041-1345
PY  - 1999///0415
KW  - Administration, Oral
KW  - Chemistry, Pharmaceutical
KW  - Cyclosporine
KW  - administration & dosage
KW  - Follow-Up Studies
KW  - Humans
KW  - Immunosuppressive Agents
KW  - Kidney Transplantation
KW  - immunology
KW  - Metabolic Clearance Rate
KW  - Time Factors
N1  - Publication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/s0041-1345(98)01646-7
ER  -